Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis-Reference-Cited by-同舟云学术

Cannabinoid receptor 2 activation alleviates diabetes-induced cardiac dysfunction, inflammation, oxidative stress, and fibrosis

Published:2022-04-22 Issue:3 Volume:44 Page:1727-1741
ISSN:2509-2715
Container-title:GeroScience
language:en
Short-container-title:GeroScience

Author:

Rajesh Mohanraj,Mukhopadhyay Partha,Bátkai Sándor,Arif Muhammad,Varga Zoltán V.,Mátyás Csaba,Paloczi Janos,Lehocki Andrea,Haskó György,Pacher Pal^ORCID

Funder

National Institute on Alcohol Abuse and Alcoholism

Publisher

Springer Science and Business Media LLC

Subject

Geriatrics and Gerontology,Aging

Link

https://link.springer.com/content/pdf/10.1007/s11357-022-00565-9.pdf

Reference54 articles.

1. Ryder JR, Northrop E, Rudser KD, Kelly AS, Gao Z, Khoury PR, Kimball TR, Dolan LM, Urbina EM. Accelerated early vascular aging among adolescents with obesity and/or type 2 diabetes mellitus. J Am Heart Assoc. 2020;9:e014891.

2. Cigolle CT, Blaum CS, Halter JB. Diabetes and cardiovascular disease prevention in older adults. Clin Geriatr Med. 2009;25:607–41, vii–viii.

3. Kirkman MS, Briscoe VJ, Clark N, Florez H, Haas LB, Halter JB, Huang ES, Korytkowski MT, Munshi MN, Odegard PS, Pratley RE, Swift CS. Diabetes in older adults. Diabetes Care. 2012;35:2650–64.

4. Milicevic Z, Raz I, Beattie SD, Campaigne BN, Sarwat S, Gromniak E, Kowalska I, Galic E, Tan M, Hanefeld M. Natural history of cardiovascular disease in patients with diabetes. Diabetes Care. 2008;31:S155–60.

5. Rubler S, Dlugash J, Yuceoglu YZ, Kumral T, Branwood AW, Grishman A. New type of cardiomyopathy associated with diabetic glomerulosclerosis. Am J Cardiol. 1972;30:595–602.

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cannabinoid Receptor-2 agonist AM1241 Attenuates Myocardial Ischemia-Reperfusion-Induced Oxidative Stress in Rats via Nrf2/HO-1 Pathway;Medical Principles and Practice;2024-08-12

2. Patent review of cannabinoid receptor type 2 (CB ₂ R) modulators (2016-present);Expert Opinion on Therapeutic Patents;2024-07-02

3. Re-evaluation of the cardioprotective effects of cannabinoids against ischemia-reperfusion injury according to the IMproving Preclinical Assessment of Cardioprotective Therapies (IMPACT) criteria;Frontiers in Pharmacology;2024-05-30

4. Curcumin prevents high glucose-induced stimulatory effects of renal cell secretome on fibroblast activation via mitigating intracellular free radicals and TGF-β secretion;Biomedicine & Pharmacotherapy;2024-05

5. Cardiotoxic effects of common and emerging drugs: role of cannabinoid receptors;Clinical Science;2024-03